ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-update on methodological approaches and results interpretation

Leukemia
J MalcikovaEuropean Research Initiative on Chronic Lymphocytic Leukemia (ERIC) — TP53 network

Abstract

In chronic lymphocytic leukemia (CLL), TP53 gene defects, due to deletion of the 17p13 locus and/or mutation(s) within the TP53 gene, are associated with resistance to chemoimmunotherapy and a particularly dismal clinical outcome. On these grounds, analysis of TP53 aberrations has been incorporated into routine clinical diagnostics to improve patient stratification and optimize therapeutic decisions. The predictive implications of TP53 aberrations have increasing significance in the era of novel targeted therapies, i.e., inhibitors of B-cell receptor (BcR) signaling and anti-apoptotic BCL2 family members, owing to their efficacy in patients with TP53 defects. In this report, the TP53 Network of the European Research Initiative on Chronic Lymphocytic Leukemia (ERIC) presents updated recommendations on the methodological approaches for TP53 mutation analysis. Moreover, it provides guidance to ensure that the analysis is performed in a timely manner for all patients requiring treatment and that the data is interpreted and reported in a consistent, standardized, and accurate way. Since next-generation sequencing technologies are gaining prominence within diagnostic laboratories, this report also offers advice and recommendations fo...Continue Reading

References

Nov 7, 1999·The American Journal of Pathology·C WilliamsJ Lundeberg
Jan 3, 2001·The New England Journal of Medicine·H DöhnerP Lichter
Feb 5, 2003·Nature Genetics·Patrick DumontMaureen Murphy
Feb 1, 2005·The Journal of Molecular Diagnostics : JMD·Mansour AkbariHans E Krokan
Feb 4, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Davide RossiGianluca Gaidano
Aug 11, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thorsten ZenzStephan Stilgenbauer
Sep 28, 2010·Leukemia Research·Norafiza ZainuddinRichard Rosenquist
Apr 13, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David GonzalezGareth J Morgan
May 19, 2011·Proceedings of the National Academy of Sciences of the United States of America·Isaac KindeBert Vogelstein
Feb 3, 2012·Leukemia·S PospisilovaUNKNOWN European Research Initiative on CLL (ERIC)
May 26, 2012·Proceedings of the National Academy of Sciences of the United States of America·Karolina EdlundThierry Soussi
Aug 8, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kirsten FischerClemens-Martin Wendtner
Jun 22, 2013·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Robert C GreenUNKNOWN American College of Medical Genetics and Genomics
May 20, 2014·American Journal of Clinical Pathology·Ming-Tseh LinJames R Eshleman
Aug 6, 2014·Molecular Diagnosis & Therapy·Guoli ChenJames R Eshleman
Dec 21, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Barbara KantorovaSarka Pospisilova
Sep 24, 2015·Nature Reviews. Molecular Cell Biology·Søren Lykke-Andersen, Torben Heick Jensen
Oct 16, 2015·Nature·Dan A LandauCatherine J Wu
Mar 5, 2016·Human Mutation·Johan T den DunnenPeter E M Taschner
Jun 9, 2016·International Journal of Cancer. Journal International Du Cancer·Gregory LazarianFanny Baran-Marszak
Aug 19, 2016·Nature·Monkol LekUNKNOWN Exome Aggregation Consortium

❮ Previous
Next ❯

Citations

Sep 18, 2018·Expert Opinion on Pharmacotherapy·Laura S Samples, Solomon A Graf
Jan 29, 2019·Expert Review of Hematology·Adalgisa Condoluci, Davide Rossi
Jan 4, 2019·Blood·Panagiotis BaliakasUNKNOWN ERIC, the European Research Initiative on CLL
Jan 29, 2019·Journal of Molecular Cell Biology·Marcus J G W Ladds, Sonia Laín
May 18, 2019·American Society of Clinical Oncology Educational Book·Danielle BranderJacqueline C Barrientos
Feb 4, 2019·Journal of Clinical Pathology·Mark A CatherwoodPatrick Thornton
Jan 18, 2018·Scientific Reports·Amanda S KahnSally P Leys
Sep 29, 2019·Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia·Kamila StranskaMichael Doubek
Jan 25, 2020·Annual Review of Pathology·Ferran NadeuElías Campo
Jun 21, 2019·Oncotarget·Marta BrunettiFrancesca Micci
Jul 29, 2020·Blood Research·Jieun Uhm
Mar 7, 2020·Frontiers in Genetics·Crescenzio Francesco MinerviniFrancesco Albano
Jun 20, 2020·Expert Opinion on Investigational Drugs·Fortunato MorabitoManlio Ferrarini
Mar 14, 2020·Cancers·Riccardo MoiaGianluca Gaidano
Oct 6, 2020·Expert Opinion on Therapeutic Targets·Riccardo MoiaGianluca Gaidano
Jan 15, 2020·Cold Spring Harbor Perspectives in Medicine·Nathanael G Bailey, Kojo S J Elenitoba-Johnson
Dec 6, 2020·Genes, Chromosomes & Cancer·Maurus LocherNormann Steiner
Oct 4, 2019·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Beatrice Del PapaPaolo Sportoletti
Nov 17, 2020·Frontiers in Oncology·Paola MontiGilberto Fronza
Jan 8, 2021·Annals of Hematology·Francesc BoschMaría José Terol
Oct 23, 2020·Annals of Oncology : Official Journal of the European Society for Medical Oncology·B EichhorstUNKNOWN ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org
Jun 3, 2021·Diagnostics·Claudia Pérez-CarreteroJesús María Hernández-Rivas
May 28, 2021·Frontiers in Oncology·Pablo OppezzoNicholas Chiorazzi

❮ Previous
Next ❯

Methods Mentioned

BETA
chromosomal aberrations
PCR
biopsies
density gradient centrifugation
deamination
electrophoresis
biopsy
flow cytometry

Software Mentioned

ClinVar
Seshat
GLASS
Mutalyzer

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.